Northwest Biotherapeutics: Q1 Earnings Snapshot

BETHESDA, Md. (AP) — BETHESDA, Md. (AP) — Northwest Biotherapeutics Inc. (NWBO) on Wednesday reported a loss of $10.7 million in its first quarter.

The Bethesda, Maryland-based company said it had a loss of 1 cent per share.

The cancer drug developer posted revenue of $880,000 in the period.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on NWBO at

Copyright © 2023 . All rights reserved. This website is not intended for users located within the European Economic Area.